Ping Hou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Ping Hou has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Tao Xu
Zhongshan School of Medicine, Sun Yat-Sen University, China
2 shared publications Huizhen Lin
Department of Immunology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou 510080, China
1 shared publicationMinghui Chen
Department of Immunology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou 510080, China
1 shared publication- Qianmu Yuan
School of Computer Science and Engineering, Sun Yat-sen University, Guangzhou, China
1 shared publication Ruining Wang
Department of Immunology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou 510080, China
1 shared publication- Ruining Wang
Zhongshan School of Medicine, Sun Yat-sen University 1 Department of Immunology Guangzhou, China
1 shared publication
Latest Publications
- 13 May 2024
- Published by Elsevier in International Immunopharmacology
- Vol. 134, 112237
Inhibition of Lck/Fyn kinase activity promotes the differentiation of induced Treg cells through AKT/mTOR pathway
- 13 May 2024
- Published by Elsevier in International Immunopharmacology
- Vol. 134, 112237
Inhibition of Lck/Fyn kinase activity promotes the differentiation of induced Treg cells through AKT/mTOR pathway
- Open Access
- 7 February 2024
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 221 (3)
TCR signaling induces STAT3 phosphorylation to promote TH17 cell differentiation
TH17 differentiation is critically controlled by “signal 3” of cytokines (IL-6/IL-23) through STAT3. However, cytokines alone induced only a moderate level of STAT3 phosphorylation. Surprisingly, TCR stimulation alone induced STAT3 phosphorylation through Lck/Fyn, and synergistically with IL-6/IL-23 induced robust and optimal STAT3 phosphorylation at Y705. Inhibition of Lck/Fyn kinase activity by Srci1 or disrupting the interaction between Lck/Fyn and STAT3 by disease-causing STAT3 mutations selectively impaired TCR stimulation, but not cytokine-induced STAT3 phosphorylation, which consequently abolished TH17 differentiation and converted them to FOXP3+ Treg cells. Srci1 administration or disrupting the interaction between Lck/Fyn and STAT3 significantly ameliorated TH17 cell–mediated EAE disease. These findings uncover an unexpected deterministic role of TCR signaling in fate determination between TH17 and Treg cells through Lck/Fyn-dependent phosphorylation of STAT3, which can be exploited to develop therapeutics selectively against TH17-related autoimmune diseases. Our study thus provides insight into how TCR signaling could integrate with cytokine signal to direct T cell differentiation.
- 7 February 2024
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 221 (3)
Open AccessTCR signaling induces STAT3 phosphorylation to promote TH17 cell differentiation
TH17 differentiation is critically controlled by “signal 3” of cytokines (IL-6/IL-23) through STAT3. However, cytokines alone induced only a moderate level of STAT3 phosphorylation. Surprisingly, TCR stimulation alone induced STAT3 phosphorylation through Lck/Fyn, and synergistically with IL-6/IL-23 induced robust and optimal STAT3 phosphorylation at Y705. Inhibition of Lck/Fyn kinase activity by Srci1 or disrupting the interaction between Lck/Fyn and STAT3 by disease-causing STAT3 mutations selectively impaired TCR stimulation, but not cytokine-induced STAT3 phosphorylation, which consequently abolished TH17 differentiation and converted them to FOXP3+ Treg cells. Srci1 administration or disrupting the interaction between Lck/Fyn and STAT3 significantly ameliorated TH17 cell–mediated EAE disease. These findings uncover an unexpected deterministic role of TCR signaling in fate determination between TH17 and Treg cells through Lck/Fyn-dependent phosphorylation of STAT3, which can be exploited to develop therapeutics selectively against TH17-related autoimmune diseases. Our study thus provides insight into how TCR signaling could integrate with cytokine signal to direct T cell differentiation.